Evolution of cardiac risk factors management among patients aged 65 years and more with coronary artery disease;Evolution du contrôle des facteurs de risque cardiovasculaire chez les patients coronariens de plus de 65 ans

Revue Medicale Suisse

Volumn 2, Issue 56, 2006, Pages 658-663

  Hobi, A ^a   Roy, S ^b   Vuille, Cédric ^c   Darioli, Roger ^e   Perdrix, Jean ^d  

^a Hopital Cantonal de Fribourg   (Switzerland)

^b EPFL   (Switzerland)

^c CLINIQUE DE GENOLIER   (Switzerland)

^d POLICLINIQUE MÉDICALE UNIVERSITAIRE   (Switzerland)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; REHABILITATION CENTER; SWITZERLAND; CORONARY ARTERY ATHEROSCLEROSIS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MIDDLE AGED; OBESITY; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING CESSATION;

AGED; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING CESSATION; SWITZERLAND;

EID: 33646169816     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. EUROASPIRE Study Group. A European Society of Cardiology Survey of secondary prevention of coronary heart disease: Principal results. Eur Heart J 1997;18:1569-82.
2. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Eur Heart J 2001;22:554-72.
3. Irving J, Oram H, Boyd J, et al. Ten year audit of secondary prevention in coronary bypass patients. BMJ 2000;321:22-3.
4. Pasquali SK, Alexander KP, Peterson ED. Cardiac rehabilitation in the elderly. Am Heart J 2001;142:748-55.
5. Lavie CJ, Milani R. Benefits of cardiac rehabilitation in the elderly. Chest 2004;126:1010-2.
6. Jenni D, Osterwalder R, Osswald S, Buser P, Pfisterer M. Evidence for age-based rationing in a Swiss University Hospital. Swiss Med Wkly 2001;131:630-4.
7. Pyörälä K, De Backer G, Graham I, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertention. Eur Heart J 1994;15:1300-31.
8. Smith SC, Blair SN, Criqui MH, Fletcher GF, Fuster V, et al. Preventing heart attack and death in patients with coronary disease. Circulation 1995;92:2-4
9. Task Force. Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 1997;18:394-413.
10. Gibbons RJ, Chatterjee K, Daley J, Douglas JS, et al. ACC/AHA/ACP-ASIM Chronic Stable Angina Guidelines. J Am Coll Card 1999;33:2092-197.
11. Erhardt LR. Barriers to effective implementation of guideline recommendations. Am J Med 2005;118 (Suppl. 12A):36-41.
12. Hobbs FDR, Erhardt L. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: The reassessing european attitudes about cardiovascular treatment (REACT) survey. Fam Pract 2002;19:596-604.
13. Canbana MD, Rand CS, Power NR, Wu AW, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement JAMA 1999;282:1458-65.
14. LaBresh KA, Ellrodt AG, Gliklich R, Liljestrand J, Peto R. Get with the guidelines for cardiovascular secondary prevention: Pilot results. Arch Intern Med 2004;164:203-9.
15. Smaha LA. The American Heart Association get with the guidelines program. Am Heart J 2004;148(Suppl. 5): S46-S48.
16. Muntwyler J, Noseda G, Darioli R, et al. National survey on prescription of cardiovascular drugs among outpatients with coronary artery disease in Switzerland. Swiss Med Wkly 2003;133:88-92.
17. Willich SN, Müller-Nordhorn J, Kulig M, et al, for the PIN Study Group. Cardiac risk factors, medication, and recurrent clinical events after acute coronary disease. A prospective cohort study. Eur Heart J 2001;22:307-13.